Conexiant
Login
  • Corneal Physician
  • Glaucoma Physician
  • New Retinal Physician
  • Ophthalmology Management
  • Ophthalmic Professional
  • Presbyopia Physician
  • Retinal Physician
The Ophthalmologist
  • Explore

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Anterior Segment
    • Glaucoma
    • Retina

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Cataract
    • Cornea
    • Glaucoma
    • Neuro-ophthalmology
    • Oculoplastics
    • Pediatric
    • Retina
  • Business

    Business & Profession

    • Professional Development
    • Business and Entrepreneurship
    • Practice Management
    • Health Economics & Policy
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Podcasts
Subscribe
Subscribe

False

Advertisement
The Ophthalmologist / Issues / 2020 / Dec / Cornea Contra COVID-19
Anterior Segment Cornea Research & Innovations

Cornea Contra COVID-19

Unlike Zika and herpes simplex, SARS-CoV-2 does not replicate in corneal tissue

By Aleksandra Jones 12/3/2020 1 min read

Share

Figure 1. Rajendra Apte, Washington University School of Medicine.

Some viruses, such as herpes simplex (HSV) or Zika, can infect the cornea and use this entry point to spread to other parts of the body – especially in immunocompromised patients. Does SARS-CoV-2 have this ability?

Researchers weren’t sure until a recent study by a team at Washington University School of Medicine in St. Louis, showed that the cornea appears to resist infection from the novel coronavirus. Led by Jonathan J. Miner, Assistant Professor of Medicine, Molecular Microbiology, and Pathology and Immunology and Rajendra Apte, Paul A. Cibis Distinguished Professor of Ophthalmology and Visual Sciences at Washington University School of Medicine, the team exposed mouse and human corneas to the virus and identified substances in corneal tissue that inhibited viral growth.

That isn’t a free pass to take off the eye protection – it’s still unknown whether tear ducts or the conjunctiva are vulnerable to the virus – but COVID-19 is unlikely to be transmitted through corneal transplant or similar procedures.

References

  1. JJ Miner et al., Cell Rep, 33 (2020). PMID: 33147451.

About the Author(s)

Aleksandra Jones

Having edited several technical publications over the last decade, I crossed paths with quite a few of Texere's current team members, and I only ever heard them sing the company's praises. When an opportunity arose to join Texere, I jumped at the chance! With a background in literature, I love the company's ethos of producing genuinely engaging content, and the fact that it is so well received by our readers makes it even more rewarding.

More Articles by Aleksandra Jones

Related Content

Newsletters

Receive the latest Ophthalmology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

False

Advertisement

False

Advertisement

Explore More in Ophthalmology

Dive deeper into the world of Ophthalmology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement
The Ophthalmologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.

Disclaimer

The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: